NEW YORK, NY / ACCESS Newswire / June 8, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

You might also be interested in reading Ambrosus Core Launches a $10 Million Developer Grant to Scale Its Open-Source Blockchain Ecosystem.